QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
A Study in Postoperative Pancreatic Fistula
- Status
- UNKNOWN
- Phase
- N/A
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Chyle Leak After Pancreatic Operation
- Status
- UNKNOWN
- Phase
- N/A
QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE1
A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase I Trial of LY3143921 Hydrate in Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Oncologic Outcomes Based on Clinical Pattern of Preoperative PET-CT in Resected Pancreatic Cancer
- Status
- COMPLETED
- Phase
- N/A
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
- Status
- TERMINATED
- Phase
- N/A
Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- NA
Immune Response After Pancreatic Cancer Treatment
- Status
- TERMINATED
- Phase
- N/A
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
- Status
- SUSPENDED
- Phase
- PHASE1
EUS BD vs ERCP TP for Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- NA
Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- N/A